Fenspar 12.5mg Patch
Prescription Required
Product introduction
Fenspar 12.5mg Patch is a pain relieving medicine. It effectively alleviates moderate to severe chronic ongoing pain. It should not be used in mild pain. It is prescribed only in cases where other alternative pain medications are inadequate.
Fenspar 12.5mg Patch is used for the treatment of moderate to severe pain
Fenspar 12.5mg Patch is used for the treatment of moderate to severe pain
Uses of Fenspar Patch
Side effects of Fenspar Patch
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youโre worried about them
Common side effects of Fenspar
- Dizziness
- Vomiting
- Nausea
- Drowsiness
- Application site redness
- Respiratory depression
- Rigidity
How to use Fenspar Patch
Use this medicine in dose and duration as advised by your doctor. Check the label before use. Make sure the skin is clean and dry. Remove the protective liner of the patch. Do not touch the sticky side. With sticky side down, place the patch evenly onto the skin.
How Fenspar Patch works
Fenspar 12.5mg Patch is an opioid analgesic (pain reliever) which is absorbed through the skin into the bloodstream. It works by decreasing the perception of pain by blocking the transmission of pain signals to the brain.
Safety advice
Alcohol
No interaction found/established
Pregnancy
CONSULT YOUR DOCTOR
Fenspar 12.5mg Patch may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Fenspar 12.5mg Patch is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Breastfeeding should be discontinued during treatment and for at least 72 hours after removal of the patch as it may cause breathing difficulty.
Breastfeeding should be discontinued during treatment and for at least 72 hours after removal of the patch as it may cause breathing difficulty.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Fenspar 12.5mg Patch helps relieve severe and long-lasting pain that is not relieved by other pain medications.
- Apply it to a clean, dry, unbroken, non-irritated area of skin. Replace it every 3 days, and apply on a different area of skin to prevent skin irritation.
- Do not expose it to a heat source such as heating pads or hot-water bottles as this may increase the amount of medicine absorbed by your body leading to increased side effects.
- It may cause dizziness, sleepiness, and headaches. Do not drive or do anything requiring concentration until you know how it affects you.
- It has a potential for addiction and may cause severe, potentially fatal side effects in an overdose. Take it strictly as per the dose and duration prescribed by your doctor.
- Do not drink alcohol or take other medicines that can cause drowsiness while using Fenspar 12.5mg Patch.
- Discontinue the medicine and inform your doctor immediately if you experience difficulty in breathing.
Fact Box
Chemical Class
Phenylpiperidine Derivatives
Habit Forming
No
Therapeutic Class
PAIN ANALGESICS
Action Class
Opioids
Patient concerns
FAQs
Is there anything I need to be careful about while on therapy with Fenspar 12.5mg Patch?
Fenspar 12.5mg Patch may cause drowsiness and dizziness, especially in the beginning of the treatment. Do not drive or work with tools or machinery if your alertness is affected. It is not advisable to drink alcohol during treatment with this medicine as it might increase sleepiness.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Schumacher MA, Basbaum AI, Way WL. Opioids Analgesics & Antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 545-46.
- Yaksh TL, WallaceIn MS. Opioids, Analgesia, and Pain Management. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmanโs: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 505-506.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 539-41.
- Fentanyl. Wooburn Green, BUCKS: Takeda UK Limited; 2005 [revised 21 Oct. 2018]. [Accessed 02 Apr. 2019] (online) Available from:
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 02 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from:
Marketer details
Name: Sparsha Pharma International Pvt Ltd
Address: Sparsha Pharma International Pvt. Ltd., H. No. 8-2-326/5, Road No.3, 3rd Floor, (Beside Banjara Hills PS), Banjara Hills, Hyderabad โ 500 034
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present